Newsletters - May-June 2000

Newsletters - May-June 2000

The FDA of the United States has issued an alert to doctors to be on the lookout for botanicals from the herb family, Aristolochia. Herbs from this family contain or may be contaminated with an ingredient called aristolochic acid that is toxic to the kidneys and is suspected of causing cancer.

Although no Americans have been reported to be injured by any of the Aristolochia botanicals, the U.S. FDA has issued the warning and is preparing to block the import of aristolochic acid-containing herbs based on 2 cases of kidney failure reported in Britain and 70 cases reported in Belgium.

For a list of plants under concern, check the FDA’s internet site located at the following address: http://www.fda.gov/opacom/hpwhats.html and click on "dietary supplements".

  1. AP WorldStream via COMTEX (Washington, June 2, 2000)

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.